ANEB - Anebulo Pharmaceuticals GAAP EPS of -$0.10 misses by $0.03 September, 09 2022 08:37 AM Anebulo Pharmaceuticals Inc. Anebulo Pharmaceuticals press release ( NASDAQ: ANEB ): Q4 GAAP EPS of -$0.10 misses by $0.03 . Cash balance was $14.5 million as of June 30, 2022. For further details see: Anebulo Pharmaceuticals GAAP EPS of -$0.10 misses by $0.03